Latest Investor Relations News

Eildon Capital Group has announced the reactivation of its Dividend and Distribution Reinvestment Plan (DRP) for the upcoming half-year distribution, offering securityholders a cost-free way to reinvest dividends into additional securities.

Cardiex Limited has successfully raised $4.1 million through a fully underwritten entitlement offer, bringing total funds raised to $6.5 million including a recent institutional placement. The offer saw strong participation from directors and key shareholders, with new shares set to be issued imminently.

AIC Mines has secured $55 million through a well-supported placement to fund major expansions at its Eloise mine and the development of the Jericho copper project, backed by strategic investor Hawke’s Point.

Warriedar Resources has successfully closed an oversubscribed Share Purchase Plan, raising $9.1 million; well above its initial $2 million target; and securing a total of $21 million in funding to accelerate exploration at its Golden Range Gold Project.

APA Group has announced a 1.7% increase in its final distribution for the six months ending June 2025, maintaining its FY25 guidance and offering a discounted reinvestment plan to securityholders.

APA Group has announced an estimated ordinary dividend of AUD 0.30 per unit for the first half of 2025, accompanied by a Dividend Reinvestment Plan offering a 1.5% discount and currency payment choices.

INOVIQ Limited has responded to ASX queries defending its announcement that its new CAR-NK-EV treatment killed 88% of breast and lung cancer cells in vitro, confirming compliance with disclosure rules and providing detailed study data.

Charter Hall has announced a 6% increase in its half-year distribution to 24.38 cents per security for the period ending June 30, 2025, signaling steady growth in its property investment returns.

Provaris Energy has responded to ASX inquiries following a notable surge in its share price and trading volume, denying any undisclosed material information while confirming engagement of a lead manager for a potential capital raising.

Invion Limited has announced a fully underwritten entitlement offer of Loyalty Options to raise capital for advancing its cancer clinical trials. The offer, led by Blue Ocean Equities and supported by CEO Prof Thian Chew, invites eligible shareholders to participate in a non-renounceable rights issue.

Noble Helium has amended its convertible note terms with Obsidian Global, postponing share conversions until refinancing or September 2025, while issuing new shares and options as part of a strategic turnaround.

Universal Biosensors has requested a voluntary suspension of its shares on the ASX, pending details of a proposed capital raising. The suspension is expected to last until the end of June or until the announcement is made.